Health Populi

APRIL 24, 2018

Biotech is roughly tied for second place with consumer health, dropping also by 7 points. There’s another piece of math worth doing here: a chasm between biotech and pharma of 17 percentage points worth of trust — that is the difference between the 55% of American trusting biotech versus 38% trusting pharma.

BioTech 185

BioTech Life Science Nursing Mental health 185

Healthcare IT Today

APRIL 25, 2024

In the fast-paced realm of pharmaceuticals, where innovation can mean the difference between life and death, the integration of artificial intelligence (AI) is reshaping the landscape of drug discovery and development. The marriage of AI and pharmaceuticals holds immense promise, particularly in the realm of drug discovery.

Pharmaceuticals 137

Pharmaceuticals Drug Development BioTech Life Science 137

FierceHealthIT

APRIL 21, 2020

million in a Series A funding round to scale up its platform that is a LinkedIn for the pharmaceutical and biotech industries. Startup H1 landed $12.9

BioTech 115

BioTech Pharmaceuticals 115

Health Populi

FEBRUARY 24, 2020

And note how Americans’ trust in hospitals — historically the top-trusted health care segment in the nation — eroded from 2018, tying with consumer health companies, and just north of biotech and life science organizations. Even trust with pharmaceutical companies increased that year.

Medical Billing 240

Medical Billing Digital Health Patient Experience Life Science 240

Health Populi

APRIL 24, 2019

In this study, the healthcare industry is comprised of five segments: hospitals and clinics; pharma; biotech (separate from pharma); consumer health (e.g., Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. over-the-counter medicines); and, health insurance.

BioTech 208

BioTech Pharmaceuticals Life Science Health Information 208

Digital Health Global

OCTOBER 11, 2023

The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges.

Life Science 167

Life Science Pharmaceuticals BioTech Leadership 167

Healthcare IT Today

JANUARY 23, 2024

Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,

Drug Development 122

Drug Development Pharmaceuticals Life Science BioTech 122

Health Populi

MARCH 11, 2021

Speaking of design, this Summit was indeed well-designed by spotlighting pragmatic representatives from these various stakeholder groups.

Health Policy 254

Health Policy Medicare Pharmaceuticals Life Science 254

Lloyd Price

NOVEMBER 10, 2018

One of the biggest gambles in biotech history is about to be tested on Wall Street. In its prospectus, Moderna set an initial target of $500 million for the offering, which would make it the largest biotech IPO in history. Unlike a typical biotech going public, Moderna has a pipeline of 21 programs, 10 of which are in human testing.

BioTech 52

BioTech Pharmaceuticals 52

Healthcare IT Today

FEBRUARY 29, 2024

Pharmaceutical companies are spending over 100 billion dollars a year on clinical research, yet the industry remains skeptical about new technology that has the power to truly transform research,” said Charles Fisher, Ph.D., Founder and CEO at Unlearn.

Pharmaceuticals 128

Pharmaceuticals BioTech Health IT Healthcare IT 128

Society for Participatory Medicine

FEBRUARY 1, 2023

Our honeymoon commenced in April with what some pharmaceutical sponsors refer to as a “mandate” to show proof of a diversity, equity, and inclusion plan “as soon as practical” in the new drug application process, further solidified by the passage of the omnibus spending package at the end of 2022.

BioTech 112

BioTech Drug Development Meaningful Use Pharmaceuticals 112

Health Populi

OCTOBER 28, 2019

patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. Over one-half of Americans blame pharmaceutical companies as most responsible for the opioid crisis, followed by physicians, whom 39% of health consumers blame, and patients, whom 38% of people blame. Exacerbating U.S.

Pharmaceuticals 136

Pharmaceuticals Medical Billing Medicare Mental health 136

Healthcare IT Today

JANUARY 8, 2024

It is key for pharmaceutical companies to recognize that efficiency does not override compliance, patient safety or regulatory standards. Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety. Dave Latshaw, CEO at BioPhy 1.

Health IT 93

Health IT Drug Development Pharmaceuticals BioTech 93

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care.

BioTech 97

BioTech Life Science Drug Development Patient Experience 97

Digital Health Global

APRIL 15, 2024

Combined, the network helps pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, and solve unique geographic and market-specific challenges. They are, however, fully owned and operated by EVERSANA.

Life Science 88

Life Science Pharmaceuticals BioTech Digital Health 88

Digital Health Global

JUNE 20, 2023

Dr. Rhodes brings more than 25 years of drug discovery, company building and strategic leadership in the biotech industry, including 18 years at Biogen. has been a senior executive/CEO, as well as a chairman, board member, and entrepreneur in multiple public and private biotech and pharma companies in the U.S. Jane Rhodes, Ph.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

Digital Health Global

AUGUST 30, 2023

QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners. The impressive AI technologies of QuantHealth have proven to save pharmaceutical companies millions, helping them bring drugs to market quicker and get patients the treatments they need.” “We

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Healthcare IT Today

APRIL 4, 2023

Dell Technologies has developed a suite of digital twin solutions that are specifically designed to accelerate the biotech development process at every stage with patient digital twins. We’ll be able to create complex protocols for studying every aspect of chronic conditions and maybe someday resolving it.

Life Science 115

Life Science BioTech Pharmaceuticals Public Health 115

Digital Health Global

MARCH 1, 2023

With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie’s leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. Mundipharma is a global pharmaceutical leader. Tanda, Aptar President and CEO.

Pharmaceuticals 68

Pharmaceuticals Leadership BioTech Digital Health 68

Healthcare IT Today

NOVEMBER 7, 2023

“This investment provides us with the resources to further advance our platform and expand our reach to additional pharma, CRO, and biotech companies in Europe and the U.S., Oramed Pharmaceuticals Inc., Raviv Pryluk, Co-Founder and CEO at PhaseV. bringing new needed treatments to patients.”

Drug Development 75

Drug Development BioTech Pharmaceuticals Health IT 75

Digital Health Global

MARCH 26, 2024

Through end-to-end joint development endeavours with biotech & pharmaceutical companies, Indivi is poised to continue its growth and success in the nascent digital biomarker industry and lead the field of science in digital measurements for neuroscience R&D.

Health Technology 88

Health Technology Digital Health BioTech Drug Development 88

Digital Health

FEBRUARY 3, 2020

After escaping the revolution in Iran, Sean Khozin found his way to the United States, harmonizing his passion for patients and data into a career that’s led him into startups, the FDA, and most recently J&J, where he’s now Global Head of Data Strategy – all while pursuing his love of music. The phrase “it’s […].

BioTech 360

BioTech Pharmaceuticals Digital Health 360

Lloyd Price

FEBRUARY 23, 2025

While giants like UnitedHealth or biotech stars like Vertex Pharmaceuticals often dominate headlines, Doximitys niche focus and execution have propelled it ahead. Comparatively, the healthcare sector has lagged in recent years, but 2025 is showing signs of a turnaround.

Telehealth 73

Telehealth Leadership Digital Health BioTech 73

Digital Health Global

FEBRUARY 5, 2024

About Solas BioVentures Solas BioVentures invests exclusively in the life science industry, focusing on early-stage biotech, medtech and digital health companies. This strategy has been validated through a number of companies in both Fund I and II and the Colucid Pharmaceuticals exit.

Life Science 88

Life Science Pharmaceuticals Medical Technology BioTech 88

Insulin Nation

AUGUST 12, 2014

Landing a $925 million deal might seem like good news…unless youre in the pharmaceutical world. Sanofi put down $150 million to get the product rollout started, according to Fierce Biotech , and that money is really just an advance for Mannkind to pay most of its share of the costs of the rollout.

BioTech 88

BioTech Pharmaceuticals 88

Health Populi

SEPTEMBER 1, 2020

COVID-19 is re-shaping all industries, especially health care. And the pharma industry is challenged along with other health care sectors.

General practice 317

General practice Mental health Patient Experience Telemedicine 317

Digital Health Global

AUGUST 2, 2023

Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He We’re excited to have Colin join us as CEO and Director of VivoSense and drive the next phase of our development. For more information, visit www.vivosense.com. We are on Twitter.

BioTech 88

BioTech Digital Health Pharmaceuticals healthcare technology 88

Digital Health Global

JUNE 10, 2024

The partnership will leverage the capabilities of both companies to develop end-to-end solutions for the pharmaceutical industry that will support the enhancement of the patient experience during self-injection of innovative drugs such as GLP-1 for instance.

Patient Experience 88

Patient Experience Digital Health BioTech Pharmaceuticals 88

Lloyd Price

JANUARY 10, 2019

HealthTech does not include Biotech, such as protein research or pharmaceuticals, and also does not include MedDev, such as devices that are implanted into the body. HealthTech defines the intersection between healthcare and technology and is also sometimes referred to as digital health. Source : [link]

BioTech 56

BioTech Pharmaceuticals Digital Health 56

Digital Health Global

MARCH 16, 2023

Both Wellington and Forbion are visionaries and highly experienced biotech investors, and we look forward to working closely with them in our efforts to transform the gene editing landscape.” “Our Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space. Forbion manages well over EUR 2.3

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Insulin Nation

NOVEMBER 4, 2016

According to a Fierce Biotech report , Novo Nordisk announced in an October 31st earnings call that it is halting research and development efforts aimed at creating an oral form of insulin. Novo Nordisk was considered the last major player in the pharmaceutical industry working towards the development of oral insulin. Trick or treat!

BioTech 65

BioTech Pharmaceuticals 65

Lloyd Price

DECEMBER 5, 2018

The acquisition of Tesaro will strengthen our pharmaceuticals business by accelerating the build of our oncology pipeline and commercial footprint, along with providing access to new scientific capabilities,” Emma Walmsley, Glaxo’s chief executive, said in a prepared statement.

BioTech 43

BioTech Pharmaceuticals 43

Lloyd Price

SEPTEMBER 30, 2024

Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. Notable Investments: Some of NVentures' significant healthcare investments include: Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. Why Healthcare?

BioTech 56

BioTech Pharmaceuticals Leadership healthcare technology 56

Society for Participatory Medicine

JANUARY 11, 2022

As a leader in patient advocacy, I am often asked to speak on the topic of patient centricity and patient advocacy from the biotech/pharma perspective. What do we mean by patient centricity or when we say that patients are at the center of what we do or patients are our guiding star?

Drug Development 81

Drug Development BioTech Patient Experience Pharmaceuticals 81

Healthcare IT Today

AUGUST 1, 2023

Our cloud-based platform unifies patient-centric data, biometrics, diagnostic tools, patient outcomes, care delivery, practitioner engagement, pharmaceuticals, and more. A member of the Sequoia Project, Parker Health is dual headquartered in Washington, DC and Dallas, TX, with offices in Menlo Park, CA. To learn more, visit ourparker.com.

BioTech 52

BioTech FHIR Pharmaceuticals Interoperability 52

Lloyd Price

DECEMBER 8, 2018

Existing investors include biotech giant Celgene Corp. , and pharmaceutical entrepreneur Robert Duggan. It had hoped to sell analytics to pharmaceutical companies as they increasingly incorporated genetic sequencing into drug development, these people say. DNA-sequencing company Illumina Inc.,

Pharmaceuticals 56

Pharmaceuticals Life Science BioTech Drug Development 56

Lloyd Price

NOVEMBER 2, 2018

In October 2018, pharmaceutical giant Pfizer and private-equity firm Bain Capital LP announced the formation of Cerevel Therapeutics LLC, a drug-discovery collaboration for central nervous system disorders. Pfizer aims to invest $150 million in biotech startups focused on neurometabolic disorders, neurodegeneration, and neuroinflammation.

BioTech 40

BioTech Pharmaceuticals 40